Cuneo, K. C., Vredenburgh, J., Desjardins, A., Peters, K., Sampson, J., Allen, K., … Kirkpatrick, J. P. (2012). Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma. In International Journal of Radiation Oncology*Biology*Physics (Vol. 84, pp. S7–S7). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2012.07.024

Cuneo, K. C., J. Vredenburgh, A. Desjardins, K. Peters, J. Sampson, K. Allen, Z. Chang, E. Duffy, B. Peterson, and J. P. Kirkpatrick. “Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma.” In International Journal of Radiation Oncology*Biology*Physics, 84:S7–S7. Elsevier BV, 2012. https://doi.org/10.1016/j.ijrobp.2012.07.024.

Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, et al. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S7–S7.

Cuneo, K. C., et al. “Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma.” International Journal of Radiation Oncology*Biology*Physics, vol. 84, no. 3, Elsevier BV, 2012, pp. S7–S7. Crossref, doi:10.1016/j.ijrobp.2012.07.024.

Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, Chang Z, Duffy E, Peterson B, Kirkpatrick JP. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S7–S7.